xadago
zambon spa - safinamidmetansulfonat - parkinsonsykdom - anti-parkinson medisiner - xadago er indisert for behandling av voksne pasienter med idiopatisk parkinsons sykdom (pd) som add-on terapi til en stabil dose levodopa (l-dopa) alene eller i kombinasjon med andre pd legemidler i midt-sent varierende pasienter.
entocort 3 mg
tillotts pharma gmbh - budesonid - depotkapsel, hard - 3 mg
nanocoll -
ge healthcare as - albumin humant kolloidale partikler ad tc-99m albumin nanokolloid - pulver til injeksjonsvæske, suspensjon
ultra technekow fm -
curium netherlands b.v. - natriummolybdat mo-99 omdannet til natriumperteknetat tc-99m - radionuklidegenerator
venticoll 0.5 mg
ge healthcare as - albumin, humant, kolloidale partikler - pulver til inhalasjonsvæske til nebulisator, oppløsning - 0.5 mg
calquence
astrazeneca ab - acalabrutinib - leukemi, lymfocytisk, kronisk, b-celle - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.
entocort 3 mg
2care4 aps - budesonid - depotkapsel, hard - 3 mg
cosopt sine 20 mg/ ml / 5 mg/ ml
santen oy - dorzolamidhydroklorid / timololmaleat - Øyedråper, oppløsning - 20 mg/ ml / 5 mg/ ml